In October, UPMC and Highmark agreed on a settlement that would bring an end to a four-year antitrust case between the two. One week later, that agreement hit some snags when Highmark proposed a clause in the agreement to guarantee UPMC would not characterize Highmark as a monopolist in litigation brought by others, including a pending lawsuit.
In that lawsuit — coined “The Royal Mile case” after one of the plaintiffs, property firm Royal Mile — four plaintiffs are accusing UPMC and Highmark of colluding to increase their rates.
UPMC argued in a federal court motion filed yesterday that “Highmark wants nothing more than to muzzle UPMC, a knowledgeable market participant,” according to the report. The system asked U.S. District Court Judge Joy Flowers Conti to enforce the agreement reached in October without the added provision.
Highmark spokesperson Aaron Billger had no immediate comment for the Pittsburgh Business Times on the motion, according to the report.
More Articles on UPMC and Highmark:
UPMC, Highmark’s Tentative Settlement on the Rocks
UPMC, Highmark Reach Tentative Agreement to End 4-Year Antitrust Fight
Lawmakers Craft Bills to Force UPMC, Highmark Resolution
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
